Results 31 to 40 of about 6,476,358 (258)

Preexposure prophylaxis for HIV infection among African women. [PDF]

, 2012
BACKGROUND: Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention of human immunodeficiency virus (HIV) infection in some trials but not in others.
FEM-PrEP Study Group, Mastro, Timothy D., Malahleha, M., Ahmed, K., Ahmed, Khatija, Fransen, K., Mastro, T. D., Makanda, M., Kiernan, H., Mastro, Timothy D, Reblin, I., Van Damme, Lut, Deese, j., Temu, Lucky, Agot, Kawango, Monedi, M. C., Mak'oketch, P., Deese, Jennifer, Owino, Fredrick, Nanda, Kavita, Kashuba, A., Mandala, Justin, Grant, R., Kapiga, S., Corneli, A., Makanda, Mankalimeng, Onyango, Jacob, Saylor, Lisa, Wong, Christina, Crucitti, Tania, Wong, C., Kirkendale, Stella, Kapiga, Saidi, Nanda, K., Taylor, Douglas, Makatu, S. E., Agot, K., Grant, Robert, Monedi, Modie Constance, Crucitti, T., Kiernan, Haddie, Kashuba, Angela, Makatu, Shumani Elsie, Mak'Oketch, Paul, Fransen, Katrien, Owino, F., Lombaard, Johan, Manongi, Rachel, Lombaard, J., Kirkendale, S., Reblin, Ilse, Onyango, J., Mandala, J., Saylor, L., Van Damme, L., Temu, L., Malahleha, Mookho, Taylor, D., Corneli, Amy, Manongi, R.   +59 more
core   +1 more source

The Burden of Rabies in Tanzania and Its Impact on Local\ud Communities [PDF]

, 2013
Rabies remains a major public health threat in many parts of the world and is responsible for an estimated 55,000 human deaths annually. The burden of rabies is estimated to be around US$20 million in Africa, with the highest financial expenditure being ...
Katie Hampson, Ferguson, H., Ferguson, Heather, Simon, C., Hampson, K., Maganga Sambo, Cleophas Simon, Hampson, Katie, Sarah Cleavel, Urassa Honorati, Urassa, H., Lembo, T., Honorati Urassa, Lembo Tiziana, Cleaveland, S., Ferguson Heather, Sambo Maganga, Lembo, Tiziana, Sambo, Maganga, Urassa, Honorati, Tiziana Lembo, Simon Cleophas, Simon, Cleophas, Hampson Katie, Cleaveland, Sarah, Sambo, M., Sarah Cleaveland, Heather Ferguson, Cleaveland Sarah   +28 more
core   +1 more source

BNT162b2 post-exposure-prophylaxis against COVID-19

, 2022
During the COVID-19 pandemic, post-exposure-vaccine-prophylaxis is not a practice. Following exposure, only patient isolation is imposed. Moreover, no therapeutic prevention approach is applied. We asked whether evidence exists for reduced mortality rate
Yehuda Warszawer, Sagit Arbel-Alon, Galit Shefer, Meytal Avgil Tsadok, Eithan Galun, Hilla Giladi, Antonello Maruotti, Giovanna Jona Lasinio, Omri Or, Zohar Shmuelian, Roy Cohen   +10 more
core   +1 more source

Exposure to hepatitis B virus, post-exposure prophylaxis knowledge, and related factors among healthcare workers in a tertiary care military facility in Ghana: A cross-sectional analytical study

Scientific African
Background: Healthcare workers are at increased risk of exposure to hepatitis B virus due to occupational hazards. Adequate knowledge and adherence to post-exposure prophylaxis protocols are crucial in minimizing HBV transmission.
Berlinda Lasidji Narh, Vivian Efua Senoo-Dogbey, Monica Charlotte Akpagloh   +2 more
doaj   +1 more source

Exposure to Biological Fluids in Dental Practice—Narrative Review on Appropriate Risk Assessment to Guide Post-Exposure Management

Pathogens, 2023
Accidental exposure to blood or other biological fluids is a common occurrence in dentistry, and its post-exposure management is a key component of infection prevention and control programs designed to prevent the transmission of blood-borne pathogens ...
Mihai Săndulescu, Mihnea Ioan Nicolescu, Cristian Funieru, Gülşen Özkaya Şahin, Oana Săndulescu   +4 more
doaj   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna   +9 more
wiley   +1 more source

Changes in HIV post-exposure prophylaxis prescriptions before and after the introduction of HIV pre-exposure prophylaxis at a sexual health clinic in Melbourne, Australia, 2011–2021

Australian and New Zealand Journal of Public Health
Objective: HIV pre-exposure prophylaxis (PrEP) became available in Victoria, Australia, in 2016. We examined non-occupational post-exposure prophylaxis (nPEP) usage among gay, bisexual and other men who have sex with men (MSM) before and after PrEP ...
Ranjit S. Samra, Christopher K. Fairley, Jason J. Ong, Ei T. Aung, Eric PF. Chow   +4 more
doaj   +1 more source

Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men

American Journal of Men's Health, 2022
People who are incarcerated have a disproportionately high risk of contracting human immunodeficiency virus (HIV). While there is no known cure for HIV, there are biomedical approaches that can successfully manage the virus and prevent its transmission ...
Pamela Valera, Zaire S. Ali, Diamond Cunningham, Christopher McLaughlin, Sebastian Acevedo   +4 more
doaj   +1 more source

Post Exposure Prophylaxis of HIV Infection for Health Care Workers [PDF]

, 2023
Health workers (HCWs) are prone to get infected by HIV infection when carrying out their duties. The injuries can be caused by needle sticks, sharp objects (scalpels, lancets, or other) that have been exposed to body fluids or splashes of body fluids ...
Karjadi, Teguh Harjono, Teguh H. Karjadi
core   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source